I. Moreno

1.3k total citations · 1 hit paper
20 papers, 1.1k citations indexed

About

I. Moreno is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, I. Moreno has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Pathology and Forensic Medicine and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in I. Moreno's work include Genetic factors in colorectal cancer (5 papers), Lung Cancer Treatments and Mutations (4 papers) and Lung Cancer Research Studies (3 papers). I. Moreno is often cited by papers focused on Genetic factors in colorectal cancer (5 papers), Lung Cancer Treatments and Mutations (4 papers) and Lung Cancer Research Studies (3 papers). I. Moreno collaborates with scholars based in Spain and Brazil. I. Moreno's co-authors include Mariano Monzó, Alfons Navarro, Ruth Zárate, Natalia Ramírez, Eva Bandrés, Jesús García‐Foncillas, Elena Cubedo, Xabier Agirre, Raquel Malumbres and Àlex Pifarré and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and British Journal of Cancer.

In The Last Decade

I. Moreno

20 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues.

2006 706 citations Eva Bandrés, Elena Cubedo et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
I. Moreno Spain	12	772	740	235	132	132	20	1.1k
MICHAEL S. KOPRESKI United States	10	438 0.6×	468 0.6×	277 1.2×	168 1.3×	110 0.8×	15	811
Shuai Xiao China	11	500 0.6×	334 0.5×	125 0.5×	68 0.5×	92 0.7×	38	672
Britta Hasemeier Germany	20	1.2k 1.6×	815 1.1×	167 0.7×	58 0.4×	98 0.7×	30	1.5k
Munmun Rahman Japan	15	537 0.7×	207 0.3×	178 0.8×	212 1.6×	90 0.7×	34	806
Saori Ushijima United Kingdom	19	1.5k 1.9×	317 0.4×	260 1.1×	96 0.7×	148 1.1×	20	1.6k
Musaffe Tuna United States	13	415 0.5×	217 0.3×	128 0.5×	96 0.7×	116 0.9×	22	673
Stephen C. Yang United States	9	1.1k 1.4×	331 0.4×	278 1.2×	76 0.6×	284 2.2×	11	1.4k
Semra Demokan Türkiye	16	684 0.9×	271 0.4×	203 0.9×	108 0.8×	74 0.6×	33	873
Julio Vázquez Spain	13	259 0.3×	430 0.6×	412 1.8×	58 0.4×	121 0.9×	32	769
Sara Junquera Spain	15	261 0.3×	491 0.7×	502 2.1×	65 0.5×	111 0.8×	21	841

Countries citing papers authored by I. Moreno

Since Specialization

Citations

This map shows the geographic impact of I. Moreno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Moreno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Moreno more than expected).

Fields of papers citing papers by I. Moreno

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Moreno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Moreno. The network helps show where I. Moreno may publish in the future.

Co-authorship network of co-authors of I. Moreno

This figure shows the co-authorship network connecting the top 25 collaborators of I. Moreno. A scholar is included among the top collaborators of I. Moreno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Moreno. I. Moreno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Moreno, I., et al.. (2021). Hipercalcemia em cadelas portadoras de neoplasia mamária malignas. SHILAP Revista de lepidopterología. 15(8). 1 indexed citations

2.

Santasusagna, Sandra, I. Moreno, Alfons Navarro, et al.. (2018). miR-328 mediates a metabolic shift in colon cancer cells by targeting SLC2A1/GLUT1. Clinical & Translational Oncology. 20(9). 1161–1167. 43 indexed citations

3.

Chaparro, María, Jordi Gordillo, Eugeni Domènech, et al.. (2015). P438. Prospective, randomized clinical trial comparing the efficacy of two vaccines against hepatitis B virus (HBV) in inflammatory bowel disease (IBD) patients. Journal of Crohn s and Colitis. 9(suppl 1). S299–S299. 1 indexed citations

4.

Artells, Rosa, I. Moreno, Tania Díaz, et al.. (2009). Tumour CD133 mRNA expression and clinical outcome in surgically resected colorectal cancer patients. European Journal of Cancer. 46(3). 642–649. 61 indexed citations

5.

Ramírez, Natalia, Eva Bandrés, Alfons Navarro, et al.. (2008). Epigenetic events in normal colonic mucosa surrounding colorectal cancer lesions. European Journal of Cancer. 44(17). 2689–2695. 28 indexed citations

6.

Bandrés, Eva, Elena Cubedo, Xabier Agirre, et al.. (2006). Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues.. Molecular Cancer. 5(1). 29–29. 706 indexed citations breakdown →

7.

Moreno, I., et al.. (2004). XPD, XPA, ERCC1 and XPG/ERCC5 single nucleotide polymorphisms (SNPs) in oxaliplatin-treated colorectal cancer (CRC). Journal of Clinical Oncology. 22(14_suppl). 3677–3677. 14 indexed citations

8.

Moreno, I., et al.. (2004). XPD, XPA, ERCC1 and XPG/ERCC5 single nucleotide polymorphisms (SNPs) in oxaliplatin-treated colorectal cancer (CRC). Journal of Clinical Oncology. 22(14_suppl). 3677–3677. 4 indexed citations

9.

Vayá, Amparo, et al.. (2003). Erythrocyte aggregability and disaggregability in thalassemia trait carriers analyzed by a laser backscattering technique.. PubMed. 28(4). 245–9. 5 indexed citations

10.

Barragán, Eva, Pascual Bolufer, I. Moreno, et al.. (2001). Quantitative Detection of AML1-ETO Rearrangement by Real-Time RT-PCR Using Fluorescently Labeled Probes. Leukemia & lymphoma. 42(4). 747–756. 15 indexed citations

11.

Montalar, Joaquín, Serafín Morales, Catalina Vadell, et al.. (2000). Vinorelbine (VNR), ifosfamide (IFO) and cisplatin (CDDP) as assitencial treatment in patients (PTS) with inoperable non small cell lung cancer (NSCLC). Lung Cancer. 29(1). 55–56. 2 indexed citations

12.

Bolufer, Pascual, Guillermo Sanz, Eva Barragán, et al.. (2000). Rapid quantitative detection of BCR-ABL transcripts in chronic myeloid leukemia patients by real-time reverse transcriptase polymerase-chain reaction using fluorescently labeled probes.. PubMed. 85(12). 1248–54. 31 indexed citations

13.

Moreno, I., et al.. (1998). Differential interactions among isolates of peanut stunt cucumovirus and its satellite RNA.. Journal of General Virology. 79(1). 177–184. 15 indexed citations

14.

Calvo, Ran, Josep‐María Ribera, Manuel Vaquero Abellán, et al.. (1997). Low-Grade, Malt-type, Primary B-Cell Lymphoma of the Conjunctiva. Leukemia & lymphoma. 28(1-2). 203–207. 10 indexed citations

15.

Pifarré, Àlex, Rafael Rosell, Mariano Monzó, et al.. (1997). Prognostic value of replication errors on chromosomes 2p and 3p in non-small-cell lung cancer. British Journal of Cancer. 75(2). 184–189. 43 indexed citations

16.

Rosell, Rafael, Mariano Monzó, Àlex Pifarré, et al.. (1996). Molecular staging of non-small cell lung cancer according to K-ras genotypes.. PubMed. 2(6). 1083–6. 41 indexed citations

17.

Rosell, Rafael, Mariano Monzó, Francisco Molina, et al.. (1995). K-ras genotypes and prognosis in non-small-cell lung cancer. Annals of Oncology. 6. S15–S20. 23 indexed citations

18.

Fernández, C. Hernández, et al.. (1989). Quality of Life During Chemotherapy in Non-Small Cell Lung Cancer Patients. Acta Oncologica. 28(1). 29–33. 60 indexed citations

19.

Rosell, R., et al.. (1989). Antiemetic Efficacy of Escalating Doses of Alizapride against Chemotherapy-Induced Emesis. Oncology. 46(4). 235–237. 1 indexed citations

20.

Rosell, R., et al.. (1987). A Randomized Study Comparing Platinum, Doxorubicin, and VP-16 With Platinum, 4′-Epidoxorubicin, and VP-16 in Patients With Non-Small-Cell Lung Cancer. American Journal of Clinical Oncology. 10(3). 245–248. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact